Veeva is one of the most investible SaaS names thanks to the industry it serves and its GAAP margins. Its legal battle with IQVIA appears to be over, and the two now partner in many areas, with IQVIA joining Veeva's CRO clinical data partner program. @JaredSleeper notes Veeva's 29% GAAP operating margin and $3.3B of ARR growing 16% a year. x.com
